Dr. Kamel is the Helen and Albert Moon Professor, Chief of Neurocritical Care, and Vice Chair for Research in the Department of Neurology at Weill Cornell Medicine. He is the Director of the Clinical and Translational Neuroscience Unit in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. His research focuses on the relationship between cardiac disease and stroke. He was a principal investigator and protocol lead for the NIH-funded ARCADIA trial, which tested antithrombotic strategies in patients with stroke and atrial cardiopathy. He is also a principal investigator of the NIH-funded ASPIRE trial, which is testing antithrombotic strategies in patients with atrial fibrillation and intracerebral hemorrhage. He serves on the NIH StrokeNet Executive Committee and chairs its Prevention Working Group. He has published over 400 scientific publications, including in leading journals such as NEJM and JAMA.